Feb 22 (Reuters) - CogState Ltd CGS.AX :
* REMAINS CONFIDENT COGSTATE IS WELL POSITIONED FOR GROWTH
AND
WILL RECOMMENCE SHARE BUYBACK
* RESOLVED TO COMMENCE A FURTHER ON-MARKET SHARE BUY-BACK OF
UP TO
5 MILLION OF ISSUED ORDINARY SHARES OVER NEXT 12 MONTHS
* EXPECT IMPROVED CLINICAL TRIALS SALES BOOKINGS IN 2H24
COMPARED
WITH 1H24
* CUSTOMER ENGAGEMENT ON NEW CLINICAL TRIALS EXPECTED TO
REMAIN
STRONG IN FY24
* EXPECT IMPROVED CLINICAL TRIALS SALES BOOKINGS IN 2H24
COMPARED
WITH 1H24
Source text for Eikon: ID:nASX6TVTd1
Further company coverage: CGS.AX
((Reuters.Briefs@thomsonreuters.com;))